Application Information

This drug has been submitted to the FDA under the reference 204726/001.

Names and composition

"SILODOSIN" is the commercial name of a drug composed of SILODOSIN.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
204726/001 SILODOSIN SILODOSIN CAPSULE/ORAL 4MG
204726/002 SILODOSIN SILODOSIN CAPSULE/ORAL 8MG
206541/001 SILODOSIN SILODOSIN CAPSULE/ORAL 4MG
206541/002 SILODOSIN SILODOSIN CAPSULE/ORAL 8MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022206/001 RAPAFLO SILODOSIN CAPSULE/ORAL 4MG
022206/002 RAPAFLO SILODOSIN CAPSULE/ORAL 8MG
204726/001 SILODOSIN SILODOSIN CAPSULE/ORAL 4MG
204726/002 SILODOSIN SILODOSIN CAPSULE/ORAL 8MG
206541/001 SILODOSIN SILODOSIN CAPSULE/ORAL 4MG
206541/002 SILODOSIN SILODOSIN CAPSULE/ORAL 8MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved